Literature DB >> 11147799

Decreased in situ insulin receptor dephosphorylation in hyperglycemia-induced insulin resistance in rat adipocytes.

S Tang1, H Le-Tien, B J Goldstein, P Shin, R Lai, I G Fantus.   

Abstract

The regulation of insulin receptor (IR) tyrosine (tyr) phosphorylation is a key step in the control of insulin signaling. Augmented IR tyr dephosphorylation by protein tyrosine phosphatases (PTPs) may contribute to insulin resistance. To investigate this possibility in hyperglycemia-induced insulin resistance, primary cultured rat adipocytes were rendered insulin-resistant by chronic exposure (18 h) to 15 mmo/l glucose combined with 10(-7) mol/l insulin. Insulin-resistant adipocytes showed a decrease in insulin sensitivity and a maximum response of 2-deoxyglucose uptake, which was associated with a decrease in maximum insulin-stimulated IR tyr phosphorylation in situ. To assess tyr dephosphorylation, IRs of insulin-stimulated permeabilized adipocytes were labeled with [gamma-32P]ATP and chased for 2 min with unlabeled ATP in the presence of EDTA. In a nonradioactive protocol, insulin-stimulated adipocytes were permeabilized and exposed to EDTA and erbstatin for 2 min, and IRs were immunoblotted with anti-phosphotyrosine (pY) antibodies. Both methods showed a similar diminished extent of IR tyr dephosphorylation in resistant cells. Immunoblotting of four candidate IR-PTPs demonstrated no change in PTP1B or the SH2 domain containing phosphatase-2 (SHP-2), whereas a significant decrease in leukocyte antigen-related phosphatase (LAR) (51 +/- 3% of control) and an increase in PTP-alpha (165 +/- 16%) were found. Activity of immunoprecipitated PTPs toward a triple tyr phosphorylated IR peptide revealed a correlation with protein content for PTP1B, SHP-2, and LAR but a decrease in apparent specific activity of PTP-alpha. The data indicate that decreased IR tyr phosphorylation in hyperglycemia-induced insulin resistance is not due to enhanced dephosphorylation. The diminished IR tyr dephosphorylation observed in this model is associated with decreased LAR protein content and activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11147799     DOI: 10.2337/diabetes.50.1.83

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  Hyperglycemia potentiates H(2)O(2) production in adipocytes and enhances insulin signal transduction: potential role for oxidative inhibition of thiol-sensitive protein-tyrosine phosphatases.

Authors:  Xiangdong Wu; Li Zhu; Assaf Zilbering; Kalyankar Mahadev; Hiroyuki Motoshima; Junli Yao; Barry J Goldstein
Journal:  Antioxid Redox Signal       Date:  2005 May-Jun       Impact factor: 8.401

2.  Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes.

Authors:  M Skrzypski; T T Le; P Kaczmarek; E Pruszynska-Oszmalek; P Pietrzak; D Szczepankiewicz; P A Kolodziejski; M Sassek; A Arafat; B Wiedenmann; K W Nowak; M Z Strowski
Journal:  Diabetologia       Date:  2011-04-21       Impact factor: 10.122

3.  Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell.

Authors:  Gareth E Lim; Guan J Huang; Nina Flora; Derek LeRoith; Christopher J Rhodes; Patricia L Brubaker
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

4.  Combined Hyperglycemia- and Hyperinsulinemia-Induced Insulin Resistance in Adipocytes Is Associated With Dual Signaling Defects Mediated by PKC-ζ.

Authors:  Huogen Lu; Elena Bogdanovic; Zhiwen Yu; Charles Cho; Lijiang Liu; Karen Ho; June Guo; Lucy S N Yeung; Reiner Lehmann; Harinder S Hundal; Adria Giacca; I George Fantus
Journal:  Endocrinology       Date:  2018-04-01       Impact factor: 4.736

5.  LipiD-QuanT: a novel method to quantify lipid accumulation in live cells.

Authors:  Hilal Varinli; Megan J Osmond-McLeod; Peter L Molloy; Pascal Vallotton
Journal:  J Lipid Res       Date:  2015-09-01       Impact factor: 5.922

6.  Effects of high glucose on caveolin-1 and insulin signaling in 3T3-L1 adipocytes.

Authors:  Sara Palacios-Ortega; Maider Varela-Guruceaga; J Alfredo Martínez; Carlos de Miguel; Fermín I Milagro
Journal:  Adipocyte       Date:  2015-12-08       Impact factor: 4.534

7.  Enhancement of insulin responsiveness by nitric oxide-mediated inactivation of protein-tyrosine phosphatases.

Authors:  Ming-Fo Hsu; Tzu-Ching Meng
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

Review 8.  Zinc transporters and zinc signaling: new insights into their role in type 2 diabetes.

Authors:  Stephen A Myers
Journal:  Int J Endocrinol       Date:  2015-04-23       Impact factor: 3.257

Review 9.  Oxidative stress and metabolic pathologies: from an adipocentric point of view.

Authors:  Soazig Le Lay; Gilles Simard; Maria Carmen Martinez; Ramaroson Andriantsitohaina
Journal:  Oxid Med Cell Longev       Date:  2014-07-20       Impact factor: 6.543

10.  Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus.

Authors:  Stephen A Myers; Alex Nield; Mark Myers
Journal:  J Nutr Metab       Date:  2012-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.